These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3611879

  • 1. [New combination chemotherapy against drug-resistant choriocarcinoma].
    Matsui H, Kobayashi O, Takamizawa H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1087-94. PubMed ID: 3611879
    [Abstract] [Full Text] [Related]

  • 2. [A study of first and second line chemotherapies in gestational choriocarcinoma].
    Matsui H, Eguchi O, Inaba N, Takamizawa H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1297-304. PubMed ID: 8258729
    [Abstract] [Full Text] [Related]

  • 3. [Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
    Fujii T, Maeda M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):593-600. PubMed ID: 3385278
    [Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H, Suzuka K, Iitsuka Y, Seki K, Sekiya S.
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [Abstract] [Full Text] [Related]

  • 5. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES.
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [Abstract] [Full Text] [Related]

  • 6. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR, Nejad B.
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [Abstract] [Full Text] [Related]

  • 7. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
    Matsui H, Suzuka K, Yamazawa K, Tanaka N, Mitsuhashi A, Seki K, Sekiya S.
    Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
    [Abstract] [Full Text] [Related]

  • 8. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC, Singh DK, Rademaker AW, Miller DS, Lurain JR.
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [Abstract] [Full Text] [Related]

  • 9. [Study on the rationale for chemotherapy of refractory choriocarcinoma].
    Katoh T, Ishige H, Kobayashi O, Takamizawa H.
    Gan To Kagaku Ryoho; 1982 May; 9(5):815-21. PubMed ID: 6191704
    [Abstract] [Full Text] [Related]

  • 10. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT, Evans AC, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB.
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [Abstract] [Full Text] [Related]

  • 11. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR, Brewer JI.
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [Abstract] [Full Text] [Related]

  • 12. [Methotrexate in gynecologic oncology].
    Isonishi S, Terashima Y.
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
    [Abstract] [Full Text] [Related]

  • 13. Management of high-risk gestational trophoblastic disease.
    Lurain JR.
    J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
    [Abstract] [Full Text] [Related]

  • 14. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2010 Jan; 55(7-8):279-84. PubMed ID: 20795339
    [Abstract] [Full Text] [Related]

  • 15. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V, Szigetvári I, Szepesi J, Végh G, Bátorfi J, Nagymányoki Z, Török M, Berkowitz RS.
    J Reprod Med; 2010 Jan; 55(5-6):253-7. PubMed ID: 20626182
    [Abstract] [Full Text] [Related]

  • 16. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE, Braga CA.
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [Abstract] [Full Text] [Related]

  • 17. [The treatment of refractory choriocarcinoma].
    Takamizawa Y, Inaba N, Matsui H.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1843-7. PubMed ID: 2393304
    [Abstract] [Full Text] [Related]

  • 18. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM, Desai A.
    J Reprod Med; 2010 Sep; 55(7-8):296-300. PubMed ID: 20795341
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
    Wang S, An R, Han X, Zhu K, Xue Y.
    Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
    [Abstract] [Full Text] [Related]

  • 20. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.